The 15 references in paper I. Shirinsky V., V. Shirinsky S., И. Ширинский В., В. Ширинский С. (2014) “ПРОГНОЗИРОВАНИЕ КЛИНИЧЕСКОЙ ЭФФЕКТИВНОСТИ ЛЕЧЕНИЯ СИМВАСТАТИНОМ У БОЛЬНЫХ РЕВМАТОИДНЫМ АРТРИТОМ // PREDICTION OF CLINICAL EFFICIENCY OF SIMVASTATIN TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS” / spz:neicon:mimmun:y:2009:i:3:p:221-226

1
Ширинский И.В., Желтова О.И., Соловьева Н.Ю., Ширинский В.С., Козлов В.А. Механизмы действия, эффективность и безопасность использования статинов при ревматоидном артрите // Российский иммунологический журнал. – 2008. – No 2-3. – С. 241.
(check this in PDF content)
2
Ширинский И.В., Желтова О.И., Соловьева Н.Ю., Ширинский В.С., Козлов В.А. Клиническая эффективность статинов при ревматоидном артрите – пилотное исследование // Медицинская иммунология. – 2007. – No 4-5. – С. 505 - 508.
(check this in PDF content)
3
Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., Healey L.A., Kaplan S.R., Liang M.H., Luthra H.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis // Arthritis Rheum. – 1988. – Vol. 31. – P. 315-324.
(check this in PDF content)
4
Boyum A. Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent // Scand. J. Clin. Lab. Invest. Suppl. – 1968. – Vol. 97. – P. 9-29.
(check this in PDF content)
5
Cohen J. A power primer. // Psychol. Bull. – 1992. – Vol. 112. – P. 155-159.
(check this in PDF content)
6
Deyo R.A., Diehr P., Patrick D.L. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation // Control. Clin. Trials. – 1991. – Vol. 12. – P. 142 - 158.
(check this in PDF content)
7
Fries J.F., Spitz P., Kraines R.G., Holman H.R. Measurement of patient outcome in arthritis // Arthritis Rheum. – 1980. – Vol. 23. – P. 137-145.
(check this in PDF content)
8
Greenwood J., Steinman L., Zamvil S.S. Statin therapy and autoimmune disease: from protein prenylation to immunomodulation // Nat. Rev. Immunol. – 2006. – Vol. 6 – P. 358-370.
(check this in PDF content)
9
McCarey D.W., McInnes I.B., Madhok R., Hampson R., Scherbakov O., Ford I., Capell H.A., Sattar N. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebocontrolled trial // Lancet. – 2004. – Vol. 363. – P. 2015 - 2021.
(check this in PDF content)
10
Prevoo M.L., van ‘t Hof M.A., Kuper H.H., van Leeuwen M.A., van de Putte L.B., van Riel P.L. Modified disease activity scores that include twentyeight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis // Arthritis Rheum. – 1995. – Vol. 38. – P. 44-48.
(check this in PDF content)
11
Seitz M., Zwicker M., Villiger P.M. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate // J. Rheumatol. – 2003. – Vol. 30. – P. 28-35.
(check this in PDF content)
12
Seitz M., Zwicker M., Wider B. Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment // J. Rheumatol. – 2001. – Vol. 28. – P. 496-501.
(check this in PDF content)
13
Swets J.A. Measuring the accuracy of diagnostic systems // Science. – 1988. – Vol. 240. – P. 1285 - 1293.
(check this in PDF content)
14
Gestel A.M., Prevoo M.L., van‘t Hof M.A., van Rijswijk M.H., van de Putte L.B., van Riel P.L. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization / International League Against Rheumatism Criteria // Arthritis Rheum. – 1996. – Vol. 39. – P. 34-40.
(check this in PDF content)
15
Yokota K., Miyazaki T., Hirano M., Akiyama Y., Mimura T. Simvastatin inhibits production of interleukin 6 (IL-6) and IL-8 and cell proliferation induced by tumor necrosis factor-alpha in fibroblastlike synoviocytes from patients with rheumatoid
(check this in PDF content)